Screening Neutral and Acidic IgG N-Glycans by High Density Electrophoresis

被引:0
|
作者
Emma R. Frears
Anthony H. Merry
John S. Axford
机构
[1] St. George's Hospital Medical School,Academic Unit of Musculoskeletal Disease
[2] Cranmer Terrace,undefined
[3] BioMed Laboratories Ltd.,undefined
来源
Glycoconjugate Journal | 1999年 / 16卷
关键词
carbohydrate PAGE; IgG glycosylation; biantennary; neutral glycan;
D O I
暂无
中图分类号
学科分类号
摘要
IgG carries bi-antennary N-linked glycans which differ in degrees of galactosylation, core fucosylation and bisecting N-acetyl glucosamine. The majority of these are non-sialyated closely related neutral structures which can be resolved by HPLC analysis, but which are difficult to separate in techniques such as fluorophore-coupled carbohydrate electrophoresis. Derivatisation with the singly charged fluorophore, 2-amino benzoic acid and separation in gels with a 30% monomer content in tris/glycine buffer enabled separation of neutral glycans. In particular, agalactosyl glycans with either a core fucose substitution or bisecting N-acetyl galactosamine could be resolved. Good separation of mono- and di-galactosylated glycans was also achieved with this system. It was shown that IgG can be separated from serum by size-exclusion and anion exchange chromatography with minimal contamination, with complete glycan release accomplished by the enzyme peptide-N-glycosidase F (F. meningosepticum). This method of resolving IgG glycans could be used to monitor patients in which glycosylation changes may have a diagnostic value, as in rheumatoid arthritis. It could also be used to monitor recombinant IgG glycosylation where routine screening is required in the biotechnology industry.
引用
收藏
页码:283 / 290
页数:7
相关论文
共 50 条
  • [41] Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
    Zhou, Hui
    Warren, Peter G.
    Froehlich, John W.
    Lee, Richard S.
    ANALYTICAL CHEMISTRY, 2014, 86 (13) : 6277 - 6284
  • [42] Hydrophilic interaction anion exchange for separation of multiply modified neutral and anionic Dictyostelium N-glycans
    Hykollari, Alba
    Malzl, Daniel
    Yan, Shi
    Wilson, Iain B. H.
    Paschinger, Katharina
    ELECTROPHORESIS, 2017, 38 (17) : 2175 - 2183
  • [43] High-mannose type N-glycans with core fucosylation and complex-type N-glycans with terminal neuraminic acid residues are unique to porcine islets
    Nanno, Yoshihide
    Shajahan, Asif
    Sonon, Roberto N.
    Azadi, Parastoo
    Hering, Bernhard J.
    Burlak, Christopher
    PLOS ONE, 2020, 15 (11):
  • [44] On-line enrichment of N-glycans by immobilized metal-affinity monolith for capillary electrophoresis analysis
    Shao, Huikai
    Reider, Balazs
    Jarvas, Gabor
    Guttman, Andras
    Jiang, Zhengjin
    Tran, N. Thuy
    Taverna, Myriam
    ANALYTICA CHIMICA ACTA, 2020, 1134 : 1 - 9
  • [45] Capillary Electrophoresis Mass Spectrometry for the Characterization of O-Acetylated N-Glycans from Fish Serum
    Jayo, Roxana G.
    Li, Jianjun
    Chen, David D. Y.
    ANALYTICAL CHEMISTRY, 2012, 84 (20) : 8756 - 8762
  • [46] Article Elevated high-mannose N-glycans hamper endometrial decidualization
    Chen, Siyi
    Zhang, Aihui
    Li, Na
    Wu, Hongpan
    Li, Yaqi
    Liu, Shuai
    Yan, Qiu
    ISCIENCE, 2023, 26 (11)
  • [47] Engineering high-specificity affinity reagents for the detection of all N-glycans
    Abnouf, Shaza
    Wu, Sheng-Cheng
    Woods, Robert J.
    Yang, Loretta
    GLYCOBIOLOGY, 2021, 31 (12) : 1756 - 1756
  • [48] A rapid sample preparation and high throughput analysis of N-glycans by magnetic bead technology and capillary electrophoresis on Applied Biosystems™ DNA sequencers
    Gautam, Natalee
    Liu, Jenkuei
    Khan, Shaheer
    Solanki-Nand, Bharti
    Kunnummal, Baburaj
    Bell, Peter A.
    GLYCOBIOLOGY, 2016, 26 (12) : 1464 - 1464
  • [49] In vivo modulation of the acidic N-glycans from rat liver dipeptidyl peptidase IV by N-propanoyl-D-mannosamine
    Stehling, P
    Grams, S
    Nuck, R
    Grunow, D
    Reutter, W
    Gohlke, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (01) : 76 - 80
  • [50] Glycoengineering of CH2 domain N-glycans of therapeutic recombinant IgG's to improve effector functions
    Raju, TS
    GLYCOBIOLOGY, 2001, 11 (10) : 932 - 932